The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Uses and Use Restrictions
Grantees may use funds provided for allowable direct and indirect costs including personnel, supplies, etc.
that advance the following activities: 1.
Implementation of relevant and essential activities to accelerate the agency?s accreditation readiness.
This includes- but is not limited to- applying for and achieving national accreditation which is entirely voluntary.
In addition, grantees will complete one or more of the following activities that advance their ability to meet or conform with the national Public Health Accreditation Board (PHAB) standards** .
Recipients may not use funds for research. * Recipients may not use funds for clinical care. * Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. * Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment.
Any such proposed spending must be identified in the budget. * The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. * Reimbursement of pre-award costs is not allowed. * It is imperative for applicants to identify the relevant funding opportunity that most closely aligns to the nature of the proposed work in order for the application to be competitive and for post award activities to remain aligned to the original proposal.
Applicants are reminded that CDC is prohibited from supporting the same project or activity from more than one funding opportunity announcement (FOA).
This award will be a continuation of funds intended only for grantees previously awarded under CDC-RFA-CD10-101101PPHF12.
State health departments, large local health departments supporting cities with populations of 1 million or more inhabitants, the District of Columbia, U.S. Territories, tribal health organizations and the general public.
OMB Circular No. A-87 applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Information on the submission of applications may be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention. Telephone: (770) 488-2700.
A review will be conducted to evaluate complete and responsive applications according to the evaluation criteria listed in funding opportunity announcement. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Section 301(a) of the Public Health Service Act , 42 U.S.C. Sections 241, as amended.
Range of Approval/Disapproval Time
From 60 to 90 days.
This is applicable for renewal upon successful reporting.
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.
Length and Time Phasing of Assistance
Grant period is 5 years from September 30, 2010-Sept 29, 2015. Grant funds are to be obligated in the budget year specified i.e., September 30, 2013-Sept 29, 2014 for this continuation award. Method of awarding/releasing assistance: lump sum.
Post Assistance Requirements
Interim progress reports, project plans and annual reports are required by program.
In addition reporting for annual and baseline program evaluation and reporting is required.
Finally financial reporting to comply with FY13 appropriation act is required.
FFR (Federal Financial Reports) are required annually.
Interim and annual progress reports are required.
No expenditure reports are required.
This is accomplished via completion of mid and annual reporting described above.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceeded $500,000). the grantee should include this requirement in all sub-recipient contracts.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of three years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
(Formula Grants (Cooperative Agreements)) FY 16 $0; FY 17 est $0; and FY 18 est $0 - Because of CFDA changes made mid-FY in FY 2013, this report includes FY13 funding from multiple sources on two FOAs (CD10-1011 and OT13-1302). In FY14, those multiple sources of funding will be allocated to individual CFDA numbers, based on funding type. In FY13, however, funding under this total CFDA was broken out as follows: (1) $14,356,640 in non-PPHF funding for the NPHII Program (CD10-1011). (2) $34,760,824 in non-PPHF funding for the Umbrella Partner Agreement (OT13-1302). (3) $887,945 in non-PPHF funding for the Umbrella Partner Agreement (OT13-1302).
Range and Average of Financial Assistance
Component I: This amount is based on population and will continue for each year of the cooperative agreement: Below 1.5 million = $100,000 1.5 million - 5 million = $200,000 5 million - 8 million = $300,000 Above 8 million = $400,000 Component II: $1 million - $2.95 million.
Regulations, Guidelines, and Literature
Regulations governing this program are published under 42 CFR 55b. Guidelines are available. 45 CFR 92, and also HHS Grants Policy Statement at www.ahrq.gov/fund/hhspolicy
Regional or Local Office
See Regional Agency Offices. Roberta Erlwein email@example.com.
Andrea W. Wooddall 4770 Buford Hwy, MS E70 , Atlanta, Georgia 30341 Email: firstname.lastname@example.org Phone: 4044986792
Criteria for Selecting Proposals